Yep, the market is betting PIQ to fail to get their products into the market place at such a scale which will provide a rerating to their share price. Management needs to stop with all the pathetic grandstanding they've being doing constantly over the last couple of years and secure some tangible deals which will guarantee revenue. Literally millions of tests, just for DKD could be sold each year, plus tens of thousands of the other three, which would be worth hundreds of millions to PIQ. Their current market cap is laughable.
Yep, the market is betting PIQ to fail to get their products...
Add to My Watchlist
What is My Watchlist?
